Corpus 1,272 assessed · 1,173 scored · 643 reproduced ≥75 · 168 flagged ·∅ 74.1/100

Publications 5 Datasets 392.5k Experiments 4.7k

Explore

Filters: 2020 ✕ Medicine ✕ clear all

5 matching publication(s)

Publication	Journal	Year	Score	Verdict
Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis. ⚑ PMID 33425745	Front Oncol	2020	48	L1 48/100 ⚑
Prediction of prognostic signatures in triple-negative breast cancer based on the differential expression analysis via NanoString nCounter immune panel. PMID 33138797	BMC Cancer	2020	72	L1 72/100
Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx. PMID 33043022	Front Med (Lausanne)	2020	78	L1 78/100
Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia. PMID 32581241	Nat Commun	2020	92	L1 92/100
Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer. ⚑ PMID 32365491	Cancers (Basel)	2020	35	L1 35/100 ⚑

Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis.⚑

PMID 33425745 · Front Oncol · 2020

L1 48/100 ⚑

Prediction of prognostic signatures in triple-negative breast cancer based on the differential expression analysis via NanoString nCounter immune panel.

PMID 33138797 · BMC Cancer · 2020

L1 72/100

Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx.

PMID 33043022 · Front Med (Lausanne) · 2020

L1 78/100

Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia.

PMID 32581241 · Nat Commun · 2020

L1 92/100

Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer.⚑

PMID 32365491 · Cancers (Basel) · 2020

L1 35/100 ⚑